Matches in Wikidata for { <http://www.wikidata.org/entity/Q67124912> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q67124912 description "clinical trial" @default.
- Q67124912 description "ensayu clínicu" @default.
- Q67124912 description "клінічне випробування" @default.
- Q67124912 name "Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)" @default.
- Q67124912 type Item @default.
- Q67124912 label "Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)" @default.
- Q67124912 prefLabel "Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)" @default.
- Q67124912 P1132 Q67124912-DA3E7229-BCA0-4605-B708-599B6EBCDE94 @default.
- Q67124912 P1476 Q67124912-800F3AB8-9227-4B2F-87E8-C67923B8C70E @default.
- Q67124912 P17 Q67124912-0928A1A3-BAD1-4110-ACE0-857E036D7B78 @default.
- Q67124912 P17 Q67124912-1035F3C7-CB42-4EF8-9EC2-C40A652B683C @default.
- Q67124912 P17 Q67124912-1CA6EACA-83DA-41DB-90CB-F0929732C89B @default.
- Q67124912 P17 Q67124912-38206537-1F71-469E-B394-322DB1B55FC7 @default.
- Q67124912 P17 Q67124912-4BFE4F3B-5640-466A-9735-6BB60E6643C0 @default.
- Q67124912 P17 Q67124912-5C3ED241-1F7B-4809-B774-AC7B276816B7 @default.
- Q67124912 P17 Q67124912-7320A69A-3D22-4252-B1E7-B65C3F619077 @default.
- Q67124912 P17 Q67124912-7EC5D2A2-9533-48F9-82C3-EFF553201A69 @default.
- Q67124912 P17 Q67124912-85241C6D-A96A-46DA-A5ED-7EFD35B28255 @default.
- Q67124912 P17 Q67124912-8C71FA09-4A5A-4770-805F-A6361AD805DA @default.
- Q67124912 P17 Q67124912-C69988E4-3093-48BB-A6E3-4C1997ED910B @default.
- Q67124912 P17 Q67124912-CC876D5B-B283-471D-B789-F09B2FB6767C @default.
- Q67124912 P2899 Q67124912-6DDDDF10-BC71-4390-9A29-40ABF7CF8252 @default.
- Q67124912 P3098 Q67124912-427E93C6-6AD4-44F8-ABC3-474D67E5B604 @default.
- Q67124912 P31 Q67124912-5AC25D46-A260-4FEA-B61E-C466F8D36C76 @default.
- Q67124912 P4844 Q67124912-49535E8F-BBC1-476F-9EEF-57DA4BF37B1F @default.
- Q67124912 P580 Q67124912-5A13E07F-958B-4B76-8116-E3226FBE6B3E @default.
- Q67124912 P582 Q67124912-A965CDD3-F0E3-486D-ADBA-E2045C2E842B @default.
- Q67124912 P6099 Q67124912-D6E41F1C-C908-423A-9EB7-B14486D08262 @default.
- Q67124912 P8363 Q67124912-48B57B8B-C076-4271-9A60-B5A62F40B072 @default.
- Q67124912 P1132 "+260" @default.
- Q67124912 P1476 "A Phase II Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Subjects With High Risk Non-muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy" @default.
- Q67124912 P17 Q142 @default.
- Q67124912 P17 Q155 @default.
- Q67124912 P17 Q16 @default.
- Q67124912 P17 Q17 @default.
- Q67124912 P17 Q30 @default.
- Q67124912 P17 Q33 @default.
- Q67124912 P17 Q34 @default.
- Q67124912 P17 Q38 @default.
- Q67124912 P17 Q408 @default.
- Q67124912 P17 Q41 @default.
- Q67124912 P17 Q43 @default.
- Q67124912 P17 Q55 @default.
- Q67124912 P2899 "+18" @default.
- Q67124912 P3098 "NCT02625961" @default.
- Q67124912 P31 Q30612 @default.
- Q67124912 P4844 Q13896859 @default.
- Q67124912 P580 "2016-02-10T00:00:00Z" @default.
- Q67124912 P582 "2022-06-15T00:00:00Z" @default.
- Q67124912 P6099 Q42824440 @default.
- Q67124912 P8363 Q78089383 @default.